GSH in Cancer Dual Roles in Carcinogenesis and Drug Resistance (PubMed, 2019) Elevated Tumour GSH as a Driver of Chemotherapy Resistance A comprehensive review published on PubMed examined GSHs dual roles in cancer biology chemopreventive in normal cells through carcinogen detoxification by GST, and pathogenic in tumour cells where elevated GSH levels are associated with tumour progression and increased resistance to chemotherapeutic drugs and radiotherapy
Safety in specific populations Older adults: Generally safe, may need dose adjustment for reduced kidney function
Without adequate levels of glutathione, the immune system does not function properly
An evolving body of evidence shows that weight reduction improves health outcomes beyond its effect on intermediary CVD risk factors
To counter this limitation, a group of GLP-1 receptor agonists (GLP-1RAs), which are resistant to DPP4-mediated degradation [32], have been developed and shown to be effective in treating T2DM and obesity [33]
Properly including excipient molecules in computational methods may be critical since a primary gap is in the understanding of the viscosity-reducing excipients mechanism of action and the balance between protein-excipient and proteinprotein interaction
